Radiosurgery for Sporadic Facial Nerve Schwannoma: An International Multi-institutional Study of 60 Cases
Durable tumor control after primary SRS for sporadic facial nerve schwannoma is achieved in most patients. Among those with HB grade I facial function at presentation, treatment with SRS harbors limited additional risk of facial paresis beyond observation alone.
Authors
- Eric E. Babajanian (ORCID: https://orcid.org/0000-0003-2070-4518)
- Jason Sheehan (ORCID: https://orcid.org/0000-0002-0025-9886)
- Simon Lloyd (ORCID: https://orcid.org/0000-0003-3433-0879)
- Justin Cottrell (ORCID: https://orcid.org/0000-0002-8434-5262)
- Douglas Kondziolka (ORCID: https://orcid.org/0000-0001-8925-7344)
- Patrick Axon (ORCID: https://orcid.org/0000-0002-7023-4684)
- Christine M. Lohse (ORCID: https://orcid.org/0000-0001-9888-7495)
- Joe Walter Kutz (ORCID: https://orcid.org/0000-0002-8041-5964)
- Nejc Steiner (ORCID: https://orcid.org/0000-0002-1762-2506)
- John P. Marinelli (ORCID: https://orcid.org/0000-0003-2350-8942)
- Georgios Mantziaris (ORCID: https://orcid.org/0000-0002-3389-8836)
- Simon Duke
- Daniele Borsetto (ORCID: https://orcid.org/0000-0003-3464-2688)
- J. Thomas Roland (ORCID: https://orcid.org/0000-0003-1181-4651)
- Matthew L. Carlson (ORCID: https://orcid.org/0000-0002-4925-8593)
- Ying Meng (ORCID: https://orcid.org/0000-0003-3180-2404)
- Michael J. Link
Institutions
- Manchester Academic Health Science Centre (GB)
- Manchester Royal Infirmary (GB)
- Cambridge University Hospitals NHS Foundation Trust (GB)
- NYU Langone Health (US)
- Southwestern Medical Center (US)
- Mayo Clinic Health System (US)
- Mayo Clinic in Arizona (US)
- Mayo Clinic in Florida (US)
- Addenbrooke's Hospital (GB)
- Neurological Surgery (US)
- University of Virginia (US)
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- Otology & Neurotology
- Published
- 2025-11-13
- DOI
- https://doi.org/10.1097/mao.0000000000004758
- Primary Topic
- Facial Nerve Paralysis Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00